Stimulant Wear-Off Effects
Your symptoms of mild fatigue, calf pain, and leg heaviness occurring approximately six hours after taking 60 mg Vyvanse are consistent with stimulant wear-off effects, not another pathology.
Understanding the Timeline
Vyvanse (lisdexamfetamine) is a prodrug that converts to d-amphetamine in your bloodstream. The pharmacokinetics show that:
- Lisdexamfetamine peaks at approximately 1 hour after dosing and rapidly declines 1, 2, 3
- D-amphetamine (the active form) peaks at 3.5-4.4 hours post-dose 1, 2
- The elimination half-life of d-amphetamine is approximately 10-11 hours in adults 1, 3
- Clinical effects typically last up to 14 hours 2, 4
At six hours post-dose, you are past the peak effect and entering the declining phase of medication activity, which explains the timing of your symptoms.
Why These Specific Symptoms Occur
The fatigue and heaviness you're experiencing represent the natural decline in stimulant effect rather than true withdrawal. Here's why:
Fatigue as wear-off: Stimulants temporarily enhance alertness and energy by increasing dopamine and norepinephrine 1, 5. As medication levels decline, you may experience a relative decrease in energy compared to the medicated state—this feels like fatigue but is actually a return toward baseline 6.
Leg symptoms (calf ache and heaviness): While less commonly discussed, peripheral vasculopathy is a recognized effect of amphetamines. The FDA label specifically warns that CNS stimulants, including Vyvanse, are associated with peripheral vasculopathy 1. Your calf discomfort and leg heaviness could represent mild vascular effects as medication levels fluctuate. Amphetamines cause vasoconstriction, and as this effect wanes, you may experience these sensations 7, 8.
Distinguishing Wear-Off from True Withdrawal
True opioid-style withdrawal (which is well-characterized in the literature) includes symptoms like runny nose, tearing, gastrointestinal upset, tremor, yawning, gooseflesh, and anxiety 9. These symptoms typically start 2-3 half-lives after the last dose and peak at 48-72 hours 9.
Your symptoms at 6 hours are too early and too mild to represent true withdrawal syndrome. With Vyvanse's 10-11 hour half-life, withdrawal symptoms wouldn't begin until approximately 20-33 hours after your last dose.
What You're Actually Experiencing
This is "rebound" or "wear-off"—a temporary dip below your unmedicated baseline as the stimulant effect dissipates. Studies show that when patients discontinue long-term stimulant treatment entirely, they often report improvements in function without worsening pain, suggesting that acute wear-off sensations are time-limited phenomena 9.
Clinical Considerations
Monitor for progression: While your current symptoms are consistent with normal wear-off, be alert for:
- Worsening leg symptoms (color changes, persistent pain, digital ulceration) which would warrant evaluation for peripheral vasculopathy 1
- Cardiovascular symptoms (chest pain, palpitations, severe headache) given that amphetamines increase blood pressure by 2-4 mmHg and heart rate by 3-6 bpm on average 1, 10, 8
Your normal blood pressure and heart rate are reassuring and argue against significant cardiovascular pathology.
Management Options
If wear-off symptoms become problematic:
- Timing adjustment: Take Vyvanse earlier in the morning to shift the wear-off period
- Dose optimization: Discuss with your prescriber whether 60 mg is optimal—some patients benefit from dose adjustments 11, 12
- Supplemental short-acting stimulant: In some cases, a small afternoon dose of immediate-release stimulant can bridge the wear-off period (though this requires careful prescriber evaluation)
Common pitfall: Don't interpret normal wear-off as medication failure or a need for dose escalation without discussing with your prescriber. The goal is functional improvement throughout your day, not elimination of all sensation of medication decline 13.
Your symptoms at six hours post-dose, with normal vital signs, are most consistent with the expected pharmacokinetic profile of Vyvanse rather than pathology requiring additional workup.